Cite
HARVARD Citation
Griffiths, R. et al. (2012). Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare. Journal of cancer epidemiology. p. . [Online].